Last Updated: May 11, 2026

CLINICAL TRIALS PROFILE FOR TRULICITY

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TRULICITY

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00734474 ↗	A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin	Completed	Berry Consultants	Phase 2/Phase 3	2008-08-01	This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
NCT00734474 ↗	A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin	Completed	Tessella Inc.	Phase 2/Phase 3	2008-08-01	This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
NCT00734474 ↗	A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin	Completed	United BioSource Corporation	Phase 2/Phase 3	2008-08-01	This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type 2 diabetes mellitus on Metformin.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TRULICITY

Condition Name

Chart
Table

Condition Name for TRULICITY
Intervention	Trials
Diabetes Mellitus, Type 2	6
Adiposity	1
Primary Polydipsia	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TRULICITY
Intervention	Trials
Diabetes Mellitus, Type 2	8
Diabetes Mellitus	7
Fatty Liver	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TRULICITY

Trials by Country

Map
Table

Trials by Country for TRULICITY
Location	Trials
United States	62
China	5
Canada	5
Germany	3
Switzerland	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TRULICITY
Location	Trials
Texas	4
Georgia	4
California	3
North Carolina	3
Illinois	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TRULICITY

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TRULICITY
Clinical Trial Phase	Trials
PHASE4	1
Phase 4	7
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TRULICITY
Clinical Trial Phase	Trials
Recruiting	5
Completed	4
Not yet recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TRULICITY

Sponsor Name

Chart
Table

Sponsor Name for TRULICITY
Sponsor	Trials
Eli Lilly and Company	4
University Hospital, Basel, Switzerland	2
Emory University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TRULICITY
Sponsor	Trials
Other	14
Industry	8
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.